Tag Archives: Tim Lugo

Analysts Offer Insights on Healthcare Companies: and Sarepta Therapeutics (NASDAQ: SRPT)

There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Sarepta Therapeutics (SRPT – Research Report) with bullish sentiments. Sarepta Therapeutics (SRPT) In a report issued on March 19, Tim Lugo

William Blair Believes Xenon (NASDAQ: XENE) Won’t Stop Here

William Blair analyst Tim Lugo maintained a Buy rating on Xenon (XENE – Research Report) on February 25. The company’s shares closed last Thursday at $19.77, close to its 52-week high of $20.73. According to TipRanks.com, Lugo is a 5-star

Biohaven Pharmaceutical Holding Co (BHVN) Gets a Buy Rating from William Blair

William Blair analyst Tim Lugo maintained a Buy rating on Biohaven Pharmaceutical Holding Co (BHVN – Research Report) on October 2. The company’s shares closed last Friday at $87.13. According to TipRanks.com, Lugo is a 5-star analyst with an average

9 Meters Biopharma (NMTR) Receives a Buy from William Blair

William Blair analyst Tim Lugo maintained a Buy rating on 9 Meters Biopharma (NMTR – Research Report) on December 7. The company’s shares closed last Monday at $0.84. According to TipRanks.com, Lugo is a 5-star analyst with an average return

Analysts Offer Insights on Healthcare Companies: and SAGE Therapeutics (NASDAQ: SAGE)

There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and SAGE Therapeutics (SAGE – Research Report) with bullish sentiments. SAGE Therapeutics (SAGE) In a report issued on November 27, Tim Lugo

Ovid Therapeutics (OVID) Receives a Buy from William Blair

In a report issued on September 30, Tim Lugo from William Blair maintained a Buy rating on Ovid Therapeutics (OVID – Research Report). The company’s shares closed last Friday at $5.76. According to TipRanks.com, Lugo is a 5-star analyst with